Study of Lenvatinib in Combination With Everolimus in Participants With Unresectable Advanced or Metastatic Renal Cell Carcinoma (RCC)
Clinical trial NCT02454478 · COMPLETED
Trial details
- NCT number
- NCT02454478
- Sponsor
- Eisai Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2017-05-29
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.